Trials / Completed
CompletedNCT01192009
Leucine Supplementation and Skeletal Muscle Disuse
Leucine and Skeletal Muscle Disuse: Clinical Anti-Atrophic Effectiveness and Related Mechanisms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- Male
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Leucine supplementation is widely known for promoting strong influence on skeletal muscle remodeling. This study aims to evaluate the effect of leucine supplementation on disuse-induced skeletal muscle atrophy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Leucine | 7.2 g of leucine during 2 weeks |
| DIETARY_SUPPLEMENT | Placebo | 7.2 g of alanine during 2 weeks |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2010-08-31
- Last updated
- 2013-02-25
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01192009. Inclusion in this directory is not an endorsement.